Led by Professor Shirley (Xiao Yu) Wu, our research is centered on advanced pharmaceutics and drug delivery technologies. The goal of our research is to develop novel drug delivery strategies and systems to enhance treatment of major diseases such as cancer & diabetes.
Innovative approaches have been undertaken to achieve this goal by integrating multidisciplinary techniques and knowledge including micro- and nanotechnology, chemistry, computer simulation, engineering, pharmaceutics, pharmacology, and oncology. Our research program is highly interdisciplinary which bridges bio-sciences, materials sciences, physical sciences with clinical applications.
We would like to thank our past and present funders and partners:
Ghavaminejad, A., Ashammakhi, N., Wu, X.Y., Khademhosseini, A., 2020. 3D Bioprinting: Crosslinking Strategies for 3D Bioprinting of Polymeric Hydrogels (Small 35/2020). Small 16, 2070195. doi:10.1002/smll.202070195
Alves, S.R., Colquhoun, A., Wu, X.Y., Silva, D.de O., 2019. Synthesis of terpolymer-lipid encapsulated diruthenium(II,III)-anti-inflammatory metallodrug nanoparticles to enhance activity against glioblastoma cancer cells. Journal of Inorganic Biochemistry.
Thombre, A.G., Wu, X.Y.S., Ende, M.T.A., (2019) Controlled Release Technology And Design Of Oral Controlled Release Dosage Forms. Chemical Engineering in the Pharmaceutical Industry: Drug Product Design, Development, and Modeling, 2nd Edition, 381–407.